Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.

CONCLUSIONS: SBRT offers a high rate of local control with low incidence of toxicity, mainly grade 1 GI toxicity and fatigue, and provides effective salvage therapy for oligometastatic extracranial pelvic and extra-pelvic gynecological tumors. PMID: 33059914 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33059914?dopt=Abstract

Source: Gynecologic Oncology - October 12, 2020 Category: Cancer & Oncology Authors: Reshko LB, Baliga S, Crandley EF, Harry Lomas IV, Richardson MK, Spencer K, Bennion N, Mikdachi HE, Irvin W, Kersh CR Tags: Gynecol Oncol Source Type: research